Acción 300642 TELLGEN CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tellgen Corporation

Acciones

300642

CNE100002P42

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 28/06/2024 		Varia. Cinco días. Varia. 1 de enero.
11,64 CNY -1,19 % Gráfico intradía de Tellgen Corporation -1,69 % -34,05 %
15/05 Tellgen Corporation aprueba el dividendo en efectivo para 2023 CI
22/04 Tellgen Corporation comunica los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Shanghai Maishi Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai Zhangke Lingyi Qifan Venture Capital Center (Limited Partnership), Tellgen Corporation
Tellgen Corporation Approves Cash Dividend for 2023
Shanghai Maishi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Shanghai Zhangke Lingyi Qifan Venture Capital Center (Limited Partnership), Tellgen Corporation
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.
Tellgen Corporation's Equity Buyback announced on February 6, 2024, has closed with 1,946,150 shares, representing 1.2% for CNY 25.98 million.
Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.
Tellgen Corporation announces an Equity Buyback for CNY 50 million worth of its shares.
Tellgen Corporation authorizes a Buyback Plan.
Tellgen Corporation Announces Board Appointments
Tellgen Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023
Tellgen Corporation, Shanghai Tellgen Diagnostic Technology Co., Ltd., Shanghai Maishi Jingwu Enterprise Management Partnership Enterprise (Limited Partnership), Yao Beier, Niu Zhengxiang and Zhan Hong agreed to acquire additional 5.71% stake in Shanghai Maishi Biotechnology Co., Ltd. from Wu Liang for CNY 1.4 million.
Tellgen Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
Tellgen Corporation Approves Cash Dividend for 2022, Payable on 23 May 2023
Tellgen Corporation Proposes Final Cash Dividend for 2022
Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Tellgen Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on October 27, 2021.
Tellgen Corporation's Equity Buyback announced on October 27, 2021, has expired with 1,062,840 shares, representing 0.65% for CNY 25.43 million.
Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on October 27, 2021.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300642
  4. Noticias Tellgen Corporation
  5. Otros idiomas